Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hwee-Siew Howe
Hypersensitivity Reactions to Biologic Disease Modifying Antirheumatic Drugs: Experience From the TTSH Singapore Biologics Registry
Clinical and Translational Allergy
Immunology
Pulmonary
Allergy
Respiratory Medicine
Related publications
Eligibility Criteria for Biologic Disease-Modifying Antirheumatic Drugs in Axial Spondyloarthritis: Going Beyond BASDAI
RMD Open
Rheumatology
Allergy
Immunology
Assessing the Effectiveness of Synthetic and Biologic Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis &Ndash; A Systematic Review
Psoriasis: Targets and Therapy
Dermatology
Rheumatology
Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis
Arthritis Care and Research
Rheumatology
Safety of Abatacept Compared With Other Biologic and Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Data From an Observational Study
Arthritis Research & Therapy
Can Patient Navigators Improve Adherence to Disease-Modifying Antirheumatic Drugs? Quantitative Findings From the Med Assist Pilot Study
Arthritis Care and Research
Rheumatology
Lipid Profiles in Rheumatoid Arthritis Patients Treated With Disease-Modifying Antirheumatic Drugs
Reumatologia
Rheumatology
Allergy
Immunology
Adherence to Disease-Modifying Antirheumatic Drugs and the Effects of Exposure Misclassification on the Risk of Hospital Admission
Arthritis Care and Research
Rheumatology
Comparative Effectiveness of Tocilizumab Versus TNF Inhibitors as Monotherapy or in Combination With Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis After the Use of at Least One Biologic Disease-Modifying Antirheumatic Drug: Analyses From the Pan-European TOCERRA Register Collaboration
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Real-World Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany
Clinical Therapeutics
Pharmacology
